Reason for request

Inclusion

-


Clinical Benefit

Substantial

Substantial


Clinical Added Value

no clinical added value

ADASUVE does not provide any improvement in actual benefit (level V, non-existent) in the rapid control of mild to moderate agitation in adult patients with schizophrenia or bipolar disorder.